Pre-dominance of dengue non-cross-reacting SARS-CoV-2 spike antibodies during the Omicron era and their role in the ADE-mediated surge of Dengue virus serotype 3
View ORCID ProfileSupratim Sarker, View ORCID ProfileChiroshri Dutta, View ORCID ProfileAbinash Mallick, View ORCID ProfileSayantan Das, Chandrika Das Chowdhury, View ORCID ProfileAbhishek De, Surajit Gorai, View ORCID ProfileSubhajit Biswas
doi: https://doi.org/10.1101/2023.09.08.23295136
Supratim Sarker
1Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, West Bengal, India
Chiroshri Dutta
1Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, West Bengal, India
Abinash Mallick
1Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, West Bengal, India
Sayantan Das
1Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, West Bengal, India
Chandrika Das Chowdhury
1Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, West Bengal, India
Abhishek De
2Department of Dermatology, Calcutta National Medical College and Hospital, Kolkata, West Bengal, India
Surajit Gorai
3Department of Dermatology, Apollo Multispeciality Hospital, Kolkata, West Bengal, India
Subhajit Biswas
1Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, West Bengal, India
4Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
Article usage
Posted September 10, 2023.
Pre-dominance of dengue non-cross-reacting SARS-CoV-2 spike antibodies during the Omicron era and their role in the ADE-mediated surge of Dengue virus serotype 3
Supratim Sarker, Chiroshri Dutta, Abinash Mallick, Sayantan Das, Chandrika Das Chowdhury, Abhishek De, Surajit Gorai, Subhajit Biswas
medRxiv 2023.09.08.23295136; doi: https://doi.org/10.1101/2023.09.08.23295136
Pre-dominance of dengue non-cross-reacting SARS-CoV-2 spike antibodies during the Omicron era and their role in the ADE-mediated surge of Dengue virus serotype 3
Supratim Sarker, Chiroshri Dutta, Abinash Mallick, Sayantan Das, Chandrika Das Chowdhury, Abhishek De, Surajit Gorai, Subhajit Biswas
medRxiv 2023.09.08.23295136; doi: https://doi.org/10.1101/2023.09.08.23295136
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2599)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12134)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4028)
- Geriatric Medicine (378)
- Health Economics (670)
- Health Informatics (2605)
- Health Policy (994)
- Hematology (358)
- HIV/AIDS (831)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3796)
- Nursing (208)
- Nutrition (562)
- Oncology (1988)
- Ophthalmology (576)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (249)
- Palliative Medicine (72)
- Pathology (470)
- Pediatrics (1098)
- Primary Care Research (443)
- Public and Global Health (6468)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (336)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)